Usually, most FVPTC cases do not harbor BRAF V600E mutation; thus, it is necessary to assess the correlation between BRAF V600E mutation and the ATX–LPA axis. This evidence concerns the gene ENPP2 and follicular variant thyroid gland papillary carcinoma.